Related Experiment Video

Updated: Mar 18, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

CBP/p300 acetyltransferase activity in hematologic malignancies

Ritika Dutta1, Bruce Tiu1, Kathleen M Sakamoto1

  • 1Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Molecular Genetics and Metabolism
|July 7, 2016
PubMed

Insights

CREB binding protein (CBP) and p300 regulate blood cell formation. Disrupting their function impairs blood cell development and renewal, potentially leading to hematologic cancers and offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Hematology
  • Cancer Biology

Background:

  • CREB binding protein (CBP) and p300 are crucial for hematopoiesis.
  • They act as transcriptional coactivators and acetyltransferases.
  • Loss of CBP/p300 function leads to hematopoietic deficiencies and stem cell disruption.

Purpose of the Study:

  • To investigate the role of CBP/p300 acetyltransferase activity in hematopoiesis.
  • To understand how disrupting this activity impacts blood cell development.
  • To explore potential therapeutic strategies for CBP/p300-related hematologic diseases.

Main Methods:

  • The abstract does not specify methods.
  • Further research would involve molecular and cellular assays.
  • In vivo and in vitro models of hematopoiesis and cancer.

Main Results:

  • The abstract does not specify results.
  • CBP/p300 dysfunction causes proliferation and differentiation defects.
  • Aberrant acetylation by CBP/p300 is linked to hematologic cancers.

Conclusions:

  • Understanding CBP/p300 acetyltransferase activity is key to treating hematologic diseases.
  • Targeting this activity could offer novel therapeutic avenues.
  • Further research is needed to elucidate specific mechanisms and therapeutic potential.

Keywords:
CBPCREB-binding proteinHematologic malignanciesLysine acetyltransferase activityTargeted therapyp300

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.1K
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

8.1K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
715
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K